Head and Neck Cancer survivor Adrian Taylor speaks about what to watch for with the disease and how you can cut your risk.
youtu.be/0YpMk6ZJluI?...
#mouthcanceractionmonth
Head and Neck Cancer survivor Adrian Taylor speaks about what to watch for with the disease and how you can cut your risk.
youtu.be/0YpMk6ZJluI?...
#mouthcanceractionmonth
Read the full NIHR research study: www.manchester.ac.uk/about/news/s...
Read the full NIHR research study: www.manchester.ac.uk/about/news/s...
My piece on the responses to the UK Covid-UK Inquiry report that try to airbrush the dead away.
Sincere thanks, @theobserveruk.bsky.social.
observer.co.uk/news/nationa...
Our Genomics in Context Awards are open now.
Read on to find out more about the call ⤵️
Our Genomics in Context Awards are open now.
Read on to find out more about the call ⤵️
Tabetha Darmon reflects on her three-decade NHS career: https://bit.ly/4oXxA8K
Tabetha Darmon reflects on her three-decade NHS career: https://bit.ly/4oXxA8K
https://nhsforest.org/green-your-site/tree-planting/
https://nhsforest.org/green-your-site/tree-planting/
Special thanks to Prof David Jaffray for a thought-provoking lecture on deploying AI in healthcare.
Special thanks to Prof David Jaffray for a thought-provoking lecture on deploying AI in healthcare.
link.springer.com/article/10.1...
#SuppOnc
link.springer.com/article/10.1...
#SuppOnc
🔗 Book your free place here: bit.ly/47VUUy0
🔗 Book your free place here: bit.ly/47VUUy0
#perinealstudyday #cancereducation
#perinealstudyday #cancereducation
This session explored why close interactions between pathology and clinical teams matters.
#perinealstudyday #cancereducation
This session explored why close interactions between pathology and clinical teams matters.
#perinealstudyday #cancereducation
Chair, Mr Damir Kosutic
Prof Omar Aziz
Miss Maija Kolehmainen
And Mr Patrick Shenjere, with six speakers still to come.
#perineal #cancer
Learn more: sites.manchester.ac.uk/from-lab-to-...
Learn more: sites.manchester.ac.uk/from-lab-to-...
#SuppOnc
#SuppOnc
Doctors hope the drug, known as VP-002, will allow for lower doses of chemotherapy, reducing its side effects and improving patient experience.
Doctors hope the drug, known as VP-002, will allow for lower doses of chemotherapy, reducing its side effects and improving patient experience.
bit.ly/44g9UV9
bit.ly/44g9UV9
🔗 Find Zoom details & recordings of past seminars here: bit.ly/4lYG65z
🔗 Find Zoom details & recordings of past seminars here: bit.ly/4lYG65z
Public misunderstanding & impact on care with @mancunianmedic.bsky.social
✅The episode explores public misunderstanding of terminology around death, dying & Advance Care Planning
🎧 speakforme.co.uk/podcast-epis...
@drkathrynmannix.bsky.social
#AdvanceCarePlanning
Public misunderstanding & impact on care with @mancunianmedic.bsky.social
✅The episode explores public misunderstanding of terminology around death, dying & Advance Care Planning
🎧 speakforme.co.uk/podcast-epis...
@drkathrynmannix.bsky.social
#AdvanceCarePlanning
But what are the potential benefits - and risks?
Watch or listen to our event 📺🎧 www.instituteforgovernment.org.uk/event/nhs-te...
But what are the potential benefits - and risks?
Watch or listen to our event 📺🎧 www.instituteforgovernment.org.uk/event/nhs-te...